Emerging digital genome technologies market

Digital Genome Market 



The digital genome market is estimated to be valued at US$ 12,000 million in 2023 and is expected to exhibit a CAGR of 10.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


The digital genome market consists of advanced genomic technologies that enable analysis, storage and interpretation of genomic data. Technologies such as next generation sequencing, polymerase chain reaction and microarrays are widely used for genomic analysis in clinical diagnostics, agricultural applications and biological research.


Market Dynamics:


Increased adoption of digital genome technologies driven by declining costs of genome sequencing. The cost of sequencing a whole human genome has declined from around $3 million in 2007 to approximately $600 in early 2020. In addition, increasing applications of digital genome technologies in clinical diagnostics is expected to drive market growth over the forecast period. For instance, genomics is increasingly being used for non-invasive prenatal testing and personalized cancer treatment. Further, rising government funding for genomic research especially in developed economies is projected to create new opportunities for market players operating in the digital genome market during the forecast period.

Market key trends:


Some of the key trends in the digital genome market include increasing use of genome sequencing in precision medicine and diagnostics. Precision medicine is a medical model using genomic data to guide clinical decision making for disease prevention, diagnosis, and treatment. With sequencing costs reducing significantly, genome and exome sequencing can be used to understand disease risk, diagnosis, and develop targeted therapies. This is expected to drive increased genome sequencing and analysis needs.


SWOT Analysis


Strengths: The digital genome market benefits from significant technological advancements in genome sequencing and data analytics. This has led to reductions in sequencing costs and improvements in sequencing speed and throughput.


Weaknesses: However, analysis and storage of massive genomic data remains a challenge due to the complexity and volume of data. Obtaining regulatory approvals for clinical applications is another challenge.


Opportunities: Increased genome sequencing adoption in clinical applications presents major growth opportunities. There is also scope for incorporating artificial intelligence and machine learning for advanced genomic data analysis.


Threats: Strict patient privacy and data security laws pose risks. Technological disruptions from newer entrants could threaten existing market players. Intense competition from global players can negatively impact certain regional players.


Key Takeaways


The Global Digital Genome Market Size was valued at US$ 7,594.8 million in 2023. It is expected to witness high growth, exhibiting a CAGR of 10.9% over the forecast period, due to increasing adoption of genome sequencing in diagnostics and precision medicine.
The North America region dominated the market in 2023 due to high adoption of genome sequencing technologies and presence of key market players in the region. However, Asia Pacific is expected to witness the highest growth during the forecast period supported by increasing healthcare investments, expansion of key market players into emerging markets, and growing genomics research.
Regional analysis
Asia Pacific region is projected to showcase the highest growthduring the forecast period, owing to growing healthcare expenditure, rising incidence of chronic diseases, increasing research activities andgrowing demand for advanced genomic diagnostic techniques. Furthermore, expanding operations of key market players along with upcoming trade agreements in various countries arealso expected to contribute to the growth of digital genome market in Asia Pacific.
Key players operating in the digital genome market include Illumina, Inc., PerkinElmer, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Limited, Nanostring Technologies, Inc., IBM Corporation, Google LLC, Amazon.com, Inc., Deep Genomics, Desktop Genetics Ltd., and Ancestry.com LLC.





Read More -   https://www.insightprobing.com/digital-genome-market-size-and-share-analysis-forecasts-growth-and-trends/


 

Comments

Post a Comment

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Image
   Windsurf Foil Board Market In the exhilarating world of water sports, the Windsurf Foil Board Market emerges as a key player, offering enthusiasts innovative equipment to enhance their riding experience. As this niche market continues to gain traction among windsurfing aficionados worldwide, it undergoes significant shifts influenced by various drivers, challenges, and geographical nuances. The Windsurf Foil Board Market size was valued at  US$ 167.4 Mn in 2024  and is expected to reach  US$ 268.6 Mn by 2031 , growing at a compound annual growth rate  (CAGR) of 7% from 2024 to 2031 Key Takeaways A prominent trend in the Windsurf Foil Board Market Demand is the increasing adoption of foil technology. Foil boards, equipped with hydrofoils beneath the waterline, enable riders to glide effortlessly above the water's surface, providing a thrilling and dynamic experience. This technological innovation has revolutionized the windsurfing landscape, attrac...
Read more

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Image
  Idiopathic Hypersomnia Treatment Market Idiopathic hypersomnia is a neurological sleep disorder characterized by excessive daytime sleepiness and long periods of sleep that does not improve even after long sleep. The treatment of idiopathic hypersomnia is done through medication and behavioral therapies. Medications like psychostimulants, serotonin modulators, wakefulness promoting agents are used to treat the condition and increase wakefulness. The increasing prevalence of idiopathic hypersomnia due to genetic and environmental factors is expected to drive the growth of the idiopathic hypersomnia treatment market. The Global Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 389.86 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Idiopathic Hypersomnia Treatment Market are Esaote SPA, Epica Animal Health, IDEXX Laboratories, Carestream Health, IMV Imaging, Fujifilm Hold...
Read more

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Image
  Niemann-Pick Disease Drug Type C Treatment Market Key Takeaways The Niemann-Pick Disease Drug Type C Treatment Market is witnessing significant growth, driven by advancements in medical research and a deeper understanding of the disease pathology. Niemann-Pick Disease Type C (NPC) is a rare genetic disorder characterized by the accumulation of cholesterol and other lipids within cells, leading to progressive neurological and visceral symptoms. With an increasing focus on rare diseases and orphan drug development, the market for NPC treatment is expanding rapidly, offering hope to patients and caregivers. Key players in the pharmaceutical industry are actively investing in research and development to bring novel therapies to market, underscoring the potential for transformative interventions in NPC management. Global Niemann-Pick Disease Drug Type C Treatment Market is estimated to be valued at  US$ 45.40  million  in 2024, and is expected to exhibit a  CAG...
Read more